Lenzilumab (Anti-CSF2 / GM-CSF)
Product Specifications
CAS Number
1229575-09-0
Synonyms
KB 003
Target
SARS-CoV
Applications
Microbiology
Additionnal Information
Lenzilumab (Anti-CSF2 / GM-CSF) is a recombinant monoclonal antibody against the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating activity. MW: 145.72 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AC-15-08 1 mL
Anti-Mouse IgG F (ab') 2 Fragment - 15nm Gold Conjugate
Sign In for Pricing
View Details 
MBS1410750-01 0.02 mg (E-Coli)
Recombinant Lactobacillus sakei subsp. sakei UPF0122 protein LCA_0713 (LCA_0713)
Sign In for Pricing
View Details MBS1410750-02 0.1 mg (E-Coli)
Recombinant Lactobacillus sakei subsp. sakei UPF0122 protein LCA_0713 (LCA_0713)
Sign In for Pricing
View Details MBS1410750-03 0.02 mg (Yeast)
Recombinant Lactobacillus sakei subsp. sakei UPF0122 protein LCA_0713 (LCA_0713)
Sign In for Pricing
View Details MBS1410750-04 0.1 mg (Yeast)
Recombinant Lactobacillus sakei subsp. sakei UPF0122 protein LCA_0713 (LCA_0713)
Sign In for Pricing
View Details MBS1410750-05 0.02 mg (Baculovirus)
Recombinant Lactobacillus sakei subsp. sakei UPF0122 protein LCA_0713 (LCA_0713)
Sign In for Pricing
View Details